The racist and classist roots of standardized testing found a home at Stanford — and they still endure today
By Georgia Rosenberg,
The Stanford Daily
| 09. 22. 2020
As wealthy parents rush to hire teachers for private instruction while those with limited financial barriers choose to take time off from school, the extent of educational inequity in the United States is more apparent than ever. Yet, such inequities are not new — they are evident throughout the development of one of the most fundamental facets of U.S. education: standardized testing. The modern field of testing found its roots here at Stanford, where eugenics shaped the notion of meritocracy, and intellectual measurement systems advertised as “objective” were designed to reinforce the social order.
Racist and Classist Roots
The inception of standardized tests in the Western world can be traced back to the Industrial Revolution and the progressive movement of the early 19th century. With these changes came a growing emphasis on education and an accompanying need to assess students on a larger scale. For Alfred Binet, the French psychologist who conceptualized the intelligence quotient (IQ), the central goal was to identify students in need of assistance by evaluating their intellectual abilites.
“Binet introduced the IQ test as a response...
Related Articles
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...